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Abstract 
Scanning electron microscopy (SEM) , 
in the backscattered electron imaging 
(BEI) mode , has been used to study the 
topographical distribution of colloidal 
gold labeled antigens expressed on the 
luminal surface of the bladder urothelium 
in biopsies from three categories of 
patients: 1) normal controls; 2) patients 
with a history of bladder cancer but no 
pathological diagnos i s at time of 
cystoscopy; and 3) patients with overt 
transitional cell carcinoma (TCC) of 
various histopathological stages and 
grades. Cold cup biopsies were processed 
for immuno-SEM according to a previously 
described method . Antigens under 
investigation were: 1) ABH blood group 
antigens; and 2) those identified by the 
following murine monoclonal antibodies 
(mAbs): LEU-Ml, T16, 19A211, G4 and 
E7. In most cases labeling patterns were 
correlated with the surface features of 
the superficial urothelial cells as 
revealed in the secondary electron 
imaging (SEI) mode of the SEM . Results, 
to date, indicate that the immuno-gold 
labeling method is more sensitive than 
immuno-peroxidase, and that phenotypic 
heterogeneity of antigenic expression (or 
deletion) is a frequent observation of 
potential diagnostic or prognostic value. 
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Introduction 
A significant number of patients 
with superficial bladder cancer progress 
to muscle invasive disease . Currently, 
there is no accurate method to identify 
these patients (14). The aim of our study 
is to characterize the antigenic 
phenotype of superficial cells of the 
bladder urothelium, normal and 
transformed at the resolution offered by 
the scanning electron microscope. 
Immuno-labeling of the ABH antigens on 
the surface of the bladder urothelium has 
been reported previously, using 
bacteriophage T4 as marker recognizable 
with the scanning electron microscope 
( 12). Immuno-labeling of the ABH 
antigens with colloidal gold has been 
reported by Nakajima et al . in a 
transmission electron microscope study of 
human salivary glands (17). Other 
antigens have been recently identified in 
the transformed bladder urothelium (2 , 8, 
9, 11); they have not, sofar, been 
studied at the resolution offered by 
electron microscope immuno-cytochemistry. 
In our studies, we took advantage of 
the striking elemental contrast generated 
by gold particles when observed in the 
backscattered electron imaging (BEI) mode 
of the scanning electron microscope 
(SEM)(4). The advantages of using 
backscattered electron imaging to study 
antigenic expression on cell surfaces 
became obvious to us during initial SEM 
studies on human peripheral blood 
leukocytes and have been recently 
reviewed (5,7) . The method was then used 
to study antigenic expression on the 
luminal surface of the bladder 
urothelium. Our initial targets were ABH 
blood group antigens, known for being 
partially deleted after malignant 
transformation, especially in cases of 
invasive bladder neoplasia 
( 3, 1 4, 18,19,21) . Ph en o t yp i c 
heterogeneity in the deletion of the ABH 
antigens was demonstrated in many cases 
of non- invasive TCCs and was described 
as a "Mosaic" labeling pattern ( 6) . The 
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word "Mosaic" was chosen to emphasize 
different levels of expression of the 
antigen on the luminal surface of 
adjacent cells, sharply delineated along 
well recognized, polygonal cell borders. 
We now report results dealing not 
only with antigens deleted during some 
steps of the transformation process, but 
also with antigens characteristically 
expressed by the transformed bladder 
urothelium, such as those described over 
the past few years by Chopin et al. (2), 
Fradet et al. ( 8, 9) and Hos hi et al. 
(11). The significance of our 
investigations has been enhanced by 
access to two distinct groups of 
patients: 1) a "normal control" group 
undergoing surgery for the correction of 
urinary stress incontinence or other 
non-neoplastic and non-inflammatory 
bladder conditions; and 2) a group of 
patients which is hereby referred to as 
"NPD/TH", i.e. no 2athological giagnosis 
at time of biopsy of the bladder mucosa 
but with well documented bladder _tumor 
history. 
The rationale of our studies is 
linked to the following hypotheses: 
1) high resolution immuno-gold labeling 
of bladder biopsies with the SEM reveals 
phenotypic changes in antigenic 
expression which are of prognostic 
significance and would not have been 
recognized with immune-peroxidase or with 
flow cytometry methods; and 2) the 
antigenic phenotype of the superficial 
cells of the urothelium reflects, as a 
slightly delayed testimony, primary 
transformation events occuring in the 
basal cell layer of the urothelium. 
Material and Methods 
Cold cup or excision biopsies were 
collected at cystoscopy using "Plasma-
lyte" (Travenol Canada Inc., Mississauga, 
Ontario) as an irrigation fluid and 
processed for immuno-SEM according to a 
previously described method (6) which 
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included the following main steps: a) 
immediate transfer of the biopsied tissue 
fragment to a fixative solution made of 
buffered 0.1% glutaraldehyde and 3% 
freshly prepared paraformaldehyde. 
"Prefixation" time was routinely 10 mi.n, 
at room temperature; b) after appropriate 
rinses in PBS supplemented with 1% 
ovalbumin and dissection of the mucosal 
layer of the biopsy fragment, the mucosa 
was incubated for 45 min with a 1/10 
dilution of the relevant monoclonal 
antibody (mAb); c) additional rinses wi.th 
PBS/ovalbumin were followed by a second 
incubation, this time with a 1/10 
dilution of a class specific goat 
anti-murine Ig adsorbed on the surface of 
40 or 30 nm colloidal gold particl.es 
(GAM-G40, or G30, Janssen Pharmaceutica, 
Beerse, Belgium); d) "postfixation" for 2 
hours with 2.5% buffered glutaraldehyde; 
e) graded ethanol dehydration and dryi.ng 
at the critical point of CO21 preceded 
conductive coating with evaporated 
carbon; f) storage of the samples in 
desiccators until examination with the 
SEM; g) for scanning electron microscopy 
a JEOL JSM #840 instrument was used 
throughout. The microscope was equipped 
with a lanthanun1 hexaboride (LaB6 ) 
cathode (Denka, Mitsui & Cy, Tokyo, 
Japan), and with a "GW #115" Summing Unit 
(GW Electronics, Inc., Norcross, GA) to 
permit the mixing of secondary (SE) and 
backscattered electron (BE) signals in 
adequate proportions. 
In all control experiments step b) 
was omitted or substituted by an 
irrelevant mAb. 
Biopsies of bladder mucosa were 
collected from: 1) "normal" control 
patients, after written consent, and 
during surgery for the correction of 
urinary stress incontinence or of other 
non-neoplastic or non-inflammatory 
urinary conditions; 2) a group of 
patients with a well documented history 
of bladder cancer but with no 
pathological diagnosis (NPD/TH) at the 
time of cystoscopy and cold cup biopsy of 
bladder mucosa; 3) cases of bladder 
transitional cell carcinoma (Ta to T3, 
grades 1 to 3); in these cases, the cold 
cup biopsies were taken from the tumor 
itself, not from adjacent or surrounding 
mucosa. 
Biopsies were frequently divided to 
test several antibodies on the same 
sample. The total number of labeling 
experiments is reported in Tables 1 and 
2. 
Surface expressed antigens 
investigated in this study were: 1) ABH 
blood group antigens recognized by 
appropriate monoclonal antibodies 
(Dakopatts a/s, Denmark); 2) antigens 
identified by LEU-Ml (10, Becton-
Dickinson, Mountain View, CA), T16 and 
19A211 (8,9), and G4 and E7 (2) murine 
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monoclonal antibodies (rnAbs). 
Histopathological controls were 
studied in all cases. Grading was 
according to the World Health 
Organization's classification (16). In 
addition, whenever a discrepancy was 
noted between the histopathological grade 
of a given tumor and the appearance of 
the mucosa under the SEM, the SEM sample 
was, after thorough SEM examination, 
embedded in paraffin and the histopatho-
logical grade reconsidered under the 
light microscope. 
Results 
The results dealing with deletion of 
ABH antigens and those illustrating 
expression of tumor associated antigens 
will be presented separately. 
ABH Antigens 
A total of 104 biopsies were 
included in this part of the study. They 
originated from 11 cases of normal 
controls, 36 cases with well documented 
history of bladder cancer but no 
pathological diagnosis at the time of 
biopsy (NPD/TH cases), 29 cases of low 
grade and 28 cases of high grade TCCs. 
The labeling patterns were 
classified into three arbitrarily defined 
groups: homogeneous labeling of most 
adjacent cells, phenotypic heterogeneity 
i.e. "mosaic" labeling pattern, and 
predominantly or completely deleted 
expression of the antigen. The results 
are summarized in Table 1, the labeling 
patterns being referred to as 
"homogeneous", "mosaic" or "deletion". 
Table 1. Expression of the ABH Antigens 






Low gr. TCC (n=29) 
High gr. TCC (n=28) 
ABH Expression 
Homog Mosaic Delet 
10 1 0 
15 19 2 
7 16 6 
4(*) 4 20 
--------------------------------------
The secretor status of the patients 
included in this study was not 
systematically tested. A small percentage 
(probably less than 10%) of the deleted 
expression may, therefore, be accounted 
for by a hypothetical non-secreter 
status. Low grade TCC included grade 1 
tumors while high grade TCC referred to 
grade 2 and 3. As already noted in our 
initial report (6) and confirmed in the 
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present study, no significant difference 
in labeling pattern was recognized among 
patients belonging to blood group A, B, 
AB, or O. Unexpectedly, homogeneous 
expression of the antigen was observed in 
4 cases of high grade TCC ( *, in Table 
1). Reviewing the histopathological 
diagnosis in these cases, one case showed 
a submucosal tumor covered by an 
apparently normal mucosa. In another case 
multiple biopsies had been taken for 
histopathology making it difficult to 
ascertain which one was equivalent to the 
sample processed for SEM. 
One example of "mosaic" labeling 
pattern is illustrated in Fig.1 a and b 
which originates from a patient from the 
NPD/TH group. Fig. la illustrates the 
surface morphology of representative 
cells viewed in the SE imaging mode. 
Fig. lb shows the same field in the BE 
imaging mode, demonstrating the 
heterogeneous deletion of the antigen, 
i.e. the mosaic pattern, clearly 
delineated along cell borders. 
The complete "deletion" could in 
some cases be interpreted as originating 
from "non-secreter" patients. Mosaic 
patterns of ABH labeling were observed in 
52% of the NPD/TH cases and in 55% of the 
low grade TCC cases. The high incidence 
of "deletion" ( 20/28) in cases of high 
grade TCC is probably somewhat in excess 
due in part to the frequent desquamation 
of the superficial cells and in part to 
the defective maturation of the 
transformed cells. 
Tumor Associated Antigens 
Ninety-seven samples were analyzed 
in this part of the study. There were 19 
normal controls, 41 from the NPD/TH 
group, 11 from patients with low grade 
TCC, and 26 from patients with high grade 
TCC. The results were classified as 
"positive" or "negative", without 
specific reference to the homogeneous or 
heterogeneous labeling pattern. Results 
are expressed as the number of positive 
identifications of a given antigen 
divided by the number of examined samples 
and are tabulated in Table 2. 
Examples of labeling patterns are 
illustrated as follows. Fig. 2 
illustrates positive labeling for the 
antigen identified by the LEU-Ml rnAb in a 
normal control sample. Fig. 3 documents 
phenotypic heterogeneity (i.e. "mosaic") 
in the expression of the LEU-Ml antigen 
in a NPD/TH case. Fig. 4 a and b 
illustrate the particular labeling 
pattern for the Tl6 antigen observed in a 
TCC grade 2, where the labeling of 
intermediate, villous cells is recognized 
through a window of desquamation of the 
superficial "umbrella" cells. Fig. 5 a 
and b show, in a NPD/TH case labeled with 
the G4 rnAb, the surface morphology of a 
superficial cell characterized by plaques 
and microridges (Fig Sa) while Fig. Sb, 
E. de Harven et al. 
Fig. la. Bladder biopsy from a patient from the NPD/TH group, 
viewed in the secondary electron (SE) imaging mode. Large 
polygonal superficial cells display the plaques and microridges 
characteristic of the normal urothelial surface. Imrnunogold 
labeling for the blood group antigen cannot be recognized in the SE 
imaging mode. 
Fig. lb. The same field as in Fig . la, viewed in the backscattered 
electron (BE) imaging mode. The colloidal gold markers is now 
clearly recognized on the surface of some of the cells, while 
sparsely represented or totally absent on others, therefore 
creating a typical mosaic labeling pattern. 
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Fig . 2 . Bladder biopsy from the normal control group, immune-gold 
labeled with the LEU-Ml mAb. Heavy labeling of the superficial 
cells is observed here in a mixed SE/BE image. 
Fig. 3. In a case from the NPD/TH group, also labeled with the 
LEU-Ml mAb, a characteristic mosaic labeling pattern is observed in 
the BE imaging mode (reverse polarity). 
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Fig. 4a. Bladder biopsy from a patient with TCC grade II, labeled 
with the T16 rnAb. Through windows of desquarnation of the 
superficial cells, urothelial cells of the intermediate layer are 
observed, in the SE imaging mode; they display an abundance of 
surface microvilli. 
Fig. 4b. The same field as in Fig. 4a, viewed in the BE imaging 
mode, demonstrating significant labeling for the antigen recognized 
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Fig. Sa. Bladder biopsy from a patient from the NPD/TH group, 
labeled with the G4 rnAb. The plaques and microridges are well 
recognized in the SE imaging mode. 
Fig. Sb. The same field as in Fig. Sa, viewed in the BE imaging 
mode (reverse polarity), clearly demonstrating that most of the 30 
nm gold marker particles are located on the microridges, not on the 
intervening plaques of this superficial urothelial cell. 
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Table 2. Expression of Tumor 
Associated Antigens on the Superficial 









Antigen identified by 
monoclonal antibodies: 
G4 E7 T16 19A211 LEU-Ml 
2/3 1/2 6/6(*) 1/2 5/6 
11/13 7/11 8/8 5/6 2/3 
3/3 2/3 2/2 1/1 2/2 
High gr.TCC 4/5 5/6 
(n=26) 
3/4 2/2 9/9 
Note that positive labeling with the T16 
mAb in normal control(*) was restricted 
to urothelial cells of the intermediate 
layer, occasionally observed through 
little "windows" of desquamation of the 
superficial cells. 
taken in the BE imaging mode of the SEM, 
clearly indicates that the majority of 
the gold labeled sites are localized on 
the crests of the microridges, but not on 
the plaques of this apparently normal 
urothelial luminal surface. 
Our analysis of antigenic expression 
has been restricted to mucosal biopsies 
i n normal controls, in NPD/TH cases, and 
to tumor biopsies in the cases of low and 
high grade TCCs. It did not involve 
mucosal biopsies adjacent to tumors and 
therefore does not illustrate tumor 
associated "field changes " (14) . 
Discussion 
Our results indicate that, as far as 
the deletion of the ABH blood group 
antigens is concerned, observations 
cannot be classified in "positive " or 
"negative " as was frequently done in the 
past, although zones of heterogeneous 
expression of the ABH antigens were 
detected by light microscopy immuno-
fluorescence by Vacant et al. (20). When 
viewed with the SEM after immune-gold 
labeling, adjacent superficial cells with 
very similar ultrastructure (6) express 
strikingly different amounts of antigen 
(the "mosaic" pattern) . This mosaic 
pattern of labeling was rarely observed 
in normal controls but was present in 
more than 50% of NPD/TH cases and low 
grade TCCs. In previous studies of cells 
from the urinary sediment, the "mosaic" 
type of deletion was never demonstrated 
(18), because single cell suspensions of 
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mixed anatomical origin were studied . 
Moreover, in many light microscopy 
studies of bladder biopsies combined with 
various approaches to immunolabeling, the 
"mosaic" also remained undetected, 
because cross-sections of the mucosal 
surface were studied. The face-view o f 
relatively large areas of the bladder 
mucosa offered by the SEM, combined with 
the high resolution of the instrument are 
unquestionably needed to observe this 
particular labeling pat tern . 
Antigenic expression in bladder 
neoplasia has to be compared with 
appropriate normal control samples of 
bladder mucosa . Our controls consisted of 
mucosal biopsies collected during surgery 
for the correction of non-neoplastic and 
non-inflammatory bladder conditions such 
as urinary stress incontinence, from 
female patients belonging to the 40-50 
year age group . These controls minimize 
the effects of age and the interference 
by inflammatory or neoplastic processes. 
We have identified the LEU-Ml antigen i n 
most of our control samples, at variance 
with the results reported by Hoshi et 
al. ( 11) . One explanation of this 
discrepancy may reside in our selection 
of better controls. Another explanation 
may involve the high sensitivity of t h e 
immune-gold labeling method which detec t s 
low levels of antigenic expression in the 
normal bladder mucosa, undetectable by 
peroxidase immune-cytochemistry . It 
should be emphasized also that the 
antigen recognized by the LEU-Ml mAb was 
initially demonstrated on the surface of 
normal, non-transformed human 
myelomonocytic cells (10), and cannot, 
therefore, be regarded as tumor-
associated. 
All the monoclonal antibodies tested 
so far gave some positive labeling in 
control samples. This cannot be explained 
by non-specific background labeling 
because control experiments, in which the 
primary monoclonal antibody was either 
omitted or substituted by an irrelevant 
mAb, gave totally negative labeling 
results. Rather, these findings support a 
statement recently made, "the search for 
specific markers of low grade papillary 
superficial bladder tumors had long been 
unsuccessful, probably due to the close 
resemblance of these cells to their 
normal counterpart" ( 9) . Cancer-
progress ion antigens ( 9) should be 
studied by immune-gold labeling in 
further attempts to validate this 
interpretation. 
The phenotypic heterogeneity which 
we initially observed in the deletion of 
the blood group antigens ( 6) , is also 
occasionally observed in the expression 
of other antigens such as that identified 
by the LEU-Ml mAb (Fig. 3). The 
significance of these observations is not 
presently clear. They may, however, 
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reflect early changes taking place in the 
basal cell layer of the urothelium. If 
this would prove to be the case, the 
phenotype of the superficial urothelium 
might be regarded as offering a slightly 
delayed testimony of primary 
transformation events taking place in the 
basal cells. 
Finally, the immuno-gold labeling of 
antigens expressed on the luminal surface 
of the bladder urothelium permits 
unequivocal correlations between the 
topographical distribution of certain 
antigen and ultrastructural features of 
cell surfaces. This is best illustrated 
in the case of the G4 mAb ( 2) which 
recognizes an antigen only on the 
microridges of the superficial cells, not 
on the intervening "plaques" of an 
asymmetric unit membrane (1,13). Further 
experiments will be needed, however, to 
verify that the antigen is not 
efficiently masked on the plaques, while 
being readily accessible on the 
microridges. Whatever final 
interpretation is reached, the 
observation could not have been made 
without the high resolution of the 
immuno-gold/SEM labeling method. 
In conclusion, immuno-gold labeling 
combined with scanning electron 
microscopy in the backscattered electron 
imaging mode has provided a new approach 
to study the antigenic phenotype of the 
luminal surface of the human bladder 
urothelium, normal and transformed. The 
observations presented in this study 
could not have been made at the 
resolution of light microscope immuno-
cytochemistry or by flow cytometry. The 
immuno-gold/SEM methodology is relatively 
simple, highly reproducible, and 
comparatively inexpensive. A one to two 
year follow-up on all the NPD/TH patients 
entered in this study is presently in 
progress and should establish whether or 
not the observation of a "mosaic" 
deletion of ABH antigens is relevant to 
the clinical prognosis of invasive 
disease of the bladder. 
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Discussion with Reviewers 
R.M. Albrecht: Were biopsies that were 
mosaics for the blood group antigens also 
mosaics for the Leu-Ml antigen or other 
antigens? 
Authors: Samples labeled for blood group 
antigens were usually not labeled for 
tumor associated antigens. We could not, 
therefore, establish such a correlation. 
R.M. Albrecht: Have the authors 
performed any double labeling studies to 
determine if the negative cells, in the 
mosaic pattern, are negative for all 
surface markers or selectively negative 
for one or more of the antigens? In the 
presence of the mosaic pattern can one 
population of cells be negative for one 
antigen while a different population of 
cells is negative for a second antigen 
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and so forth such that mixed populations 
can exist where one cell may be negative 
for several or all antigens while another 
cell may be negative for only one or two 
surface antigens? 
Authors: We have not, so far, performed 
any significant double labeling 
experiments on bladder biopsies in 
attempts to answer these interesting 
questions. 
R. M. Albrecht: Are there any 
distinguishing morphological, cytological 
or cytochemical features specific to the 
negative cells? 
Authors: Yes, there is a tendency for 
the negative cells to exhibit only sparse 
surface features. 
G. M. Hodges: What are the advantages 
provided by the GW115 Summing Unit for 
the mixing of secondary and backscattered 
electron signals over and above that 
available on the JEOL JSM840 instrument: 
Please detail the address of GW 
Electronics. 
Authors: The advantage resides in the 
possibility to control the exact 
proportion of the SE/BE signals mixing, 
instead of simply adding them up. The 
address of the company is: GW 
Electronics Inc., 6981 Peachtree 
Industrial Boulevard, Norcross, GA 30092. 
G. M. Hodges: What evidence do you have 
that the cells labeled in Fig 4a and b 
are "intermediate" ce 11 s? Furthermore, 
it is surely inappropriate to call these 
cells "villous cells". The term of 
"villous" is generally applied to finger-
like tissue processed such as 
intestinal/placental/ or chorionic villi. 
The individual cells that are part of 
such villi may be themselves patterned by 
microvilli projecting from the free 
surface of these cells (as, for example, 
illustrated in Fig 4a). 
Authors: Low magnification observation 
of that sample clearly demonstrated that 
the cells represented in Figs 4a and b 
were seen through a well delineated 
"window" of desquamation of one or a few 
superficial cells. We use the term 
"villous" in the same sense as it is 
routinely used in the SEM literature on 
"villous" lymphocytes, al though this does 
not, as you point out, correspond to the 
traditional, anatomical definition of the 
word. 
S. M. Cohen: Was 
hyperplasia in the 
or NPD/TH by 
histopathology? 
there any evidence of 
biopsies from controls 
light microscopic 
Authors: None was reported, in spite of 
the fact that all the histopathological 
slides were reviewed prior to insertion 
in this study. 
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S. M. Cohen: Was there any relationship 
of antibody expression to specific 
surface features such as uniform 
microvilli, pleomorphic microvilli, 
spaces between microvilli, microridges, 
cell junctions, etc.? 
Authors: Yes, the most interesting being 
probably that observed with the G4 
antibody which seems to recognize an 
antigen restricted to microridges, 
although we did not perform any 
experiment aimed at possibly unmasking 
the antigen in other sites. For other 
antibodies, there is a general tendency 
to label microvilli more intensely than 
the space between microvilli. So far, we 
never observed any specific distribution 
of the antigens under investigation along 
cell junctions of the superficial cells. 
J.B. Reitan: On fig. 1 a/b a mosaic 
labeling pattern is demonstrated. The 
cell without ABH-antigen marking up to 
the right looks normal in SE-mode to me, 
whereas those at the bottom are somewhat 
blurred. Is it an artifact or may be 
they are not really normal? 
Authors: You are right. We do not feel, 
however, that these cells are out of 
focus because, in that case the gold 
would no show as well as it does on the 
bottom center cell. We are left, 
therefore, with the possibility that the 
morphology of these few cells has been 
poorly preserved. 
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